The role of autophagy in Parkinson's disease: Rotenone-based modeling

Behavioral and Brain Functions

Volumn 9, Issue 1, 2013, Pages

  Xiong, Nian ^a   Xiong, Jing ^a   Jia, Min ^a   Liu, Ling ^a   Zhang, Xiaowei ^a   Chen, Zhenzhen ^a   Huang, Jinsha ^a   Zhang, Zhentao ^b   Hou, Lingling ^a   Luo, Zhijian ^c   Ghoorah, Devina ^a   Lin, Zhicheng ^d,e   Wang, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c YANGTZE UNIVERSITY   (China)

^d MCLEAN HOSPITAL   (United States)

^e The Harvard Center for Neurodegeneration & Repair   (United States)

Author keywords

Autophagosome; Autophagy; LC3; Parkinson's Desease; Pathogenesis; Rotenone

Indexed keywords

ALPHA SYNUCLEIN; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN P62; REACTIVE OXYGEN METABOLITE; ROTENONE;

ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VACUOLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; NEUROPROTECTION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELL DEATH; CELL LINE; CELL PROLIFERATION; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; PARKINSON DISEASE, SECONDARY; REACTIVE OXYGEN SPECIES; ROTENONE; TETRAZOLIUM SALTS; THIAZOLES; UNCOUPLING AGENTS;

EID: 84874929570     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-9-13     Document Type: Article

References (54)

1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 2009, 72(21 Suppl 4):S1-136.
2. Verhoef LG, Lindsten K, Masucci MG, Dantuma NP. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum Mol Genet 2002, 11(22):2689-2700. 10.1093/hmg/11.22.2689, 12374759.
3. Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy 2008, 4(7):917-919.
4. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305(5688):1292-1295. 10.1126/science.1101738, 15333840.
5. Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 2008, 283(35):23542-23556. 10.1074/jbc.M801992200, 2527094, 18566453.
6. Xiong N, Huang J, Zhang Z, Xiong J, Liu X, Jia M, Wang F, Chen C, Cao X, Liang Z. Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease. PLoS One 2009, 4(11):e7878. 10.1371/journal.pone.0007878, 2774159, 19924288.
7. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 2008, 32(1):16-25. 10.1016/j.nbd.2008.06.003, 18640276.
8. Xiong N, Jia M, Chen C, Xiong J, Zhang Z, Huang J, Hou L, Yang H, Cao X, Liang Z. Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y. Neuroscience 2011, 199:292-302.
9. Li L, Wang X, Fei X, Xia L, Qin Z, Liang Z. Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neurosci Lett 2011, 489(1):62-67. 10.1016/j.neulet.2010.11.068, 21134415.
10. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006, 443(7113):796-802. 10.1038/nature05293, 17051206.
11. Cheung ZH, Ip NY. The emerging role of autophagy in Parkinson's disease. Mol Brain 2009, 2(1):29. 10.1186/1756-6606-2-29, 2754442, 19754977.
12. Rami A. Review: autophagy in neurodegeneration: firefighter and/or incendiarist?. Neuropathol Appl Neurobiol 2009, 35(5):449-461. 10.1111/j.1365-2990.2009.01034.x, 19555462.
13. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3(12):1301-1306. 10.1038/81834, 11100151.
14. Feng Y, Liang ZH, Wang T, Qiao X, Liu HJ. Sun SG: alpha-Synuclein redistributed and aggregated in rotenone-induced Parkinson's disease rats. Neurosci Bull 2006, 22(5):288-293.
15. Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, Ghoorah D, Kong X, Lin Z, Wang T. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models. Crit Rev Toxicol 2012, 42(7):613-632. 10.3109/10408444.2012.680431, 22574684.
16. Xiong N, Zhang Z, Huang J, Chen C, Jia M, Xiong J, Liu X, Wang F, Cao X, Liang Z. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease. Gene Ther 2011, 18(4):394-402. 10.1038/gt.2010.152, 21107440.
17. Xiong N, Cao X, Zhang Z, Huang J, Chen C, Jia M, Xiong J, Liang Z, Sun S, Lin Z. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats. Biol Blood Marrow Transplant 2010, 16(11):1519-1529. 10.1016/j.bbmt.2010.06.004, 20542126.
18. Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 2009, 34(2):279-290. 10.1016/j.nbd.2009.01.016, 2757935, 19385059.
19. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 2010, 5(1):e8762. 10.1371/journal.pone.0008762, 2808242, 20098733.
20. Greenamyre JT, Cannon JR, Drolet R, Mastroberardino PG. Lessons from the rotenone model of Parkinson's disease. Trends Pharmacol Sci 2010, 31(4):141-142. author reply 142-143. -, 10.1016/j.tips.2009.12.006, 2846992, 20096940.
21. Betarbet R, Sherer TB, Greenamyre JT. Animal models of Parkinson's disease. Bioessays 2002, 24(4):308-318. 10.1002/bies.10067, 11948617.
22. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 2004, 318(1):215-224. 10.1007/s00441-004-0938-y, 15503155.
23. Landrigan PJ, Sonawane B, Butler RN, Trasande L, Callan R, Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 2005, 113(9):1230-1233. 10.1289/ehp.7571, 1280407, 16140633.
24. Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 2001, 86(2):122-127. 10.1006/enrs.2001.4264, 11437458.
25. Dhillon AS, Tarbutton GL, Levin JL, Plotkin GM, Lowry LK, Nalbone JT, Shepherd S. Pesticide/environmental exposures and Parkinson's disease in East Texas. J Agromedicine 2008, 13(1):37-48. 10.1080/10599240801986215, 19042691.
26. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M, Marras C, Bhudhikanok GS, Kasten M, Chade AR. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 2011, 119(6):866-872. 10.1289/ehp.1002839, 3114824, 21269927.
27. Ma R, Xiong N, Huang C, Tang Q, Hu B, Xiang J, Li G. Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 2009, 56(6-7):1027-1034.
28. Zhang Z, Cao X, Xiong N, Wang H, Huang J, Sun S, Liang Z, Wang T. DNA polymerase-beta is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons. Apoptosis 2010, 15(1):105-115. 10.1007/s10495-009-0425-8, 19937276.
29. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84(5):1415-1420.
30. Wadia JS, Chalmers-Redman RM, Ju WJ, Carlile GW, Phillips JL, Fraser AD, Tatton WG. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci 1998, 18(3):932-947.
31. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 1997, 411(1):77-82. 10.1016/S0014-5793(97)00669-8, 9247146.
32. Giardino I, Edelstein D, Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996, 97(6):1422-1428. 10.1172/JCI118563, 507201, 8617874.
33. Cherra SJ, Kulich SM, Uechi G, Balasubramani M, Mountzouris J, Day BW, Chu CT. Regulation of the autophagy protein LC3 by phosphorylation. J Cell Biol 2010, 190(4):533-539. 10.1083/jcb.201002108, 2928022, 20713600.
34. Kouroku Y, Fujita E, Tanida I, Ueno T, Isoai A, Kumagai H, Ogawa S, Kaufman RJ, Kominami E, Momoi T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007, 14(2):230-239. 10.1038/sj.cdd.4401984, 16794605.
35. Wang AL, Boulton ME, Dunn WA, Rao HV, Cai J, Lukas TJ, Neufeld AH. Using LC3 to monitor autophagy flux in the retinal pigment epithelium. Autophagy 2009, 5(8):1190-1193. 10.4161/auto.5.8.10087, 19855195.
36. Rusten TE, Stenmark H. p62, an autophagy hero or culprit?. Nat Cell Biol 2010, 12(3):207-209. 10.1038/ncb0310-207, 20190829.
37. Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 2009, 8(13):1986-1990. 10.4161/cc.8.13.8892, 19502794.
38. Huang J, Hao L, Xiong N, Cao X, Liang Z, Sun S, Wang T. Involvement of glyceraldehyde-3-phosphate dehydrogenase in rotenone-induced cell apoptosis: relevance to protein misfolding and aggregation. Brain Res 2009, 1279:1-8.
39. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010, 16(1):90-97. 10.1038/nm.2069, 19966812.
40. Berg TO, Fengsrud M, Stromhaug PE, Berg T, Seglen PO. Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J Biol Chem 1998, 273(34):21883-21892. 10.1074/jbc.273.34.21883, 9705327.
41. Kaiser CA, Schekman R. Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway. Cell 1990, 61(4):723-733. 10.1016/0092-8674(90)90483-U, 2188733.
42. Wang ZF, Li HL, Li XC, Zhang Q, Tian Q, Wang Q, Xu H, Wang JZ. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture. J Neurochem 2006, 98(4):1167-1175. 10.1111/j.1471-4159.2006.03956.x, 16762022.
43. Liu C, Gao Y, Barrett J, Hu B. Autophagy and protein aggregation after brain ischemia. J Neurochem 2010, 115(1):68-78. 10.1111/j.1471-4159.2010.06905.x, 3518272, 20633207.
44. Gonzalez-Polo RA, Niso-Santano M, Ortiz-Ortiz MA, Gomez-Martin A, Moran JM, Garcia-Rubio L, Francisco-Morcillo J, Zaragoza C, Soler G, Fuentes JM. Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci 2007, 97(2):448-458. 10.1093/toxsci/kfm040, 17341480.
45. Trojanowski JQ, Lee VM. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci 2000, 924:62-67.
46. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999, 14(3):180-198. 10.1006/mcne.1999.0780, 10576889.
47. Canu N, Tufi R, Serafino AL, Amadoro G, Ciotti MT, Calissano P. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells. J Neurochem 2005, 92(5):1228-1242. 10.1111/j.1471-4159.2004.02956.x, 15715672.
48. Takacs-Vellai K, Bayci A, Vellai T. Autophagy in neuronal cell loss: a road to death. Bioessays 2006, 28(11):1126-1131. 10.1002/bies.20489, 17041904.
49. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441(7095):885-889. 10.1038/nature04724, 16625204.
50. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441(7095):880-884. 10.1038/nature04723, 16625205.
51. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131(6):1149-1163. 10.1016/j.cell.2007.10.035, 18083104.
52. Klionsky DJ. Neurodegeneration: good riddance to bad rubbish. Nature 2006, 441(7095):819-820. 10.1038/441819a, 16778876.
53. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997, 12(1):25-31.
54. Komatsu M, Wang QJ, Holstein GR, Friedrich VL, Iwata J, Kominami E, Chait BT, Tanaka K, Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A 2007, 104(36):14489-14494. 10.1073/pnas.0701311104, 1964831, 17726112.